The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Derazantinib (DZB) provides antitumor efficacy regardless of line of therapy in patients (pts) with FGFR2-fusion positive advanced intrahepatic cholangiocarcinoma (iCCA).
 
Michele Droz Dit Busset
No Relationships to Disclose
 
Bassel F. El-Rayes
Honoraria - Bayer; Lexicon; RTI Health Solutions
Consulting or Advisory Role - Bayer; BTG; Loxo; Merrimack; RTI Health Solutions
Speakers' Bureau - Bristol-Myers Squibb; Lexicon
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)
 
William Proctor Harris
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Neo Therma
Research Funding - Agios (Inst); ArQule (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Halozyme (Inst); MedImmune (Inst); Nordion (Inst)
Travel, Accommodations, Expenses - Eisai
 
Nevena Damjanov
Honoraria - Daiichi Sankyo (I); Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Celgene
 
Gianluca Masi
No Relationships to Disclose
 
Lorenza Rimassa
Honoraria - Abbvie; AstraZeneca; Gilead Sciences; Roche
Consulting or Advisory Role - Amgen; ArQule; Baxter; Bayer; Celgene; Eisai; Exelixis; Incyte; Ipsen; Italfarmaco; Lilly; Sanofi; Sirtex Medical
Travel, Accommodations, Expenses - ArQule; Ipsen
 
Sherrie Bhoori
No Relationships to Disclose
 
Monica Niger
No Relationships to Disclose
 
Nicola Personeni
No Relationships to Disclose
 
Fadi S. Braiteh
Stock and Other Ownership Interests - Agios; Bristol-Myers Squibb; Clovis Oncology; Insys Therapeutics; Tesaro
Honoraria - Abbott Nutrition; Amgen; ARIAD; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; HERON; Incyte; Insys Therapeutics; Insys Therapeutics; Ipsen; Lexicon; Lilly; Taiho Pharmaceutical
Consulting or Advisory Role - Ambry Genetics; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Ipsen; Lexicon; Lilly; Merck; Merrimack; Pfizer; Regeneron; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merck; Merrimack; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bayer/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; HERON; Incyte; Insys Therapeutics; Ipsen; Lexicon; Merrimack; Novartis; Pfizer; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical; Tesaro
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Lilly; Merck Serono
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Servier
Research Funding - Amgen; Merck Serono
 
Stephan Braun
Employment - Ipsen; Parexel
Stock and Other Ownership Interests - Ipsen
 
Marc Engelhardt
Employment - Basilea
 
Mikael Saulay
Employment - Basilea
 
Brian E. Schwartz
Employment - ArQule
Leadership - ArQule
Stock and Other Ownership Interests - ArQule
Consulting or Advisory Role - California Institute for Regenerative Medicine (CIRM)
 
Julia Kazakin
Employment - ArQule
Stock and Other Ownership Interests - ArQule
 
Walid Labib Shaib
Research Funding - ArQule (Inst); Lilly (Inst)
 
Vincenzo Mazzaferro
Consulting or Advisory Role - TERUMO
Speakers' Bureau - Ipsen
 
Kyriakos P. Papadopoulos
Consulting or Advisory Role - ArQule (Inst); Bayer (Inst)
Research Funding - 3D Medicines (Inst); Abbvie (Inst); ADC Therapeutics (Inst); Amgen (Inst); ARMO BioSciences (Inst); ArQule (Inst); Calithera Biosciences (Inst); Curegenix (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Formation Biologics (Inst); Incyte (Inst); Jounce Therapeutics (Inst); MabSpace Biosciences (Inst); MedImmune (Inst); Merck (Inst); Mersana (Inst); OncoMed (Inst); Peloton Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Syros Pharmaceuticals (Inst)